Kenketsu Glovenin-I (normal human immunoglobulin IV)
/ Takeda
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 01, 2022
Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
(clinicaltrials.gov)
- P3 | N=40 | Recruiting | Sponsor: Nihon Pharmaceutical Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Immunology
January 05, 2022
Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
(clinicaltrials.gov)
- P3; N=40; Not yet recruiting; Sponsor: Nihon Pharmaceutical Co., Ltd
Clinical • New P3 trial • CNS Disorders • Immunology • MRI
October 07, 2019
"Italy set to renew tax scheme to spur investment https://t.co/B1UnPb001t"
(@Reuters)
1 to 3
Of
3
Go to page
1